company background image
ANN

AnsellASX:ANN Stock Report

Market Cap

AU$3.8b

7D

-0.3%

1Y

-21.9%

Updated

26 Oct, 2021

Data

Company Financials +
ANN fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends5/6

ANN Overview

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.

Ansell Competitors

Johnson & Johnson

NYSE:JNJ

US$431.9b

Procter & Gamble

NYSE:PG

US$340.8b

Pfizer

NYSE:PFE

US$241.9b

Honeywell International

NasdaqGS:HON

US$149.8b

Price History & Performance

Summary of all time highs, changes and price drops for Ansell
Historical stock prices
Current Share PriceAU$31.50
52 Week HighAU$31.22
52 Week LowAU$44.07
Beta0.41
1 Month Change-9.38%
3 Month Change-21.51%
1 Year Change-21.88%
3 Year Change36.36%
5 Year Change46.04%
Change since IPO22.87%

Recent News & Updates

Sep 20
Ansell Limited (ASX:ANN) Shares Could Be 38% Below Their Intrinsic Value Estimate

Ansell Limited (ASX:ANN) Shares Could Be 38% Below Their Intrinsic Value Estimate

In this article we are going to estimate the intrinsic value of Ansell Limited ( ASX:ANN ) by projecting its future...

Aug 10
Do Ansell's (ASX:ANN) Earnings Warrant Your Attention?

Do Ansell's (ASX:ANN) Earnings Warrant Your Attention?

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...

Jun 28
Ansell (ASX:ANN) Has A Rock Solid Balance Sheet

Ansell (ASX:ANN) Has A Rock Solid Balance Sheet

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

May 21
Estimating The Intrinsic Value Of Ansell Limited (ASX:ANN)

Estimating The Intrinsic Value Of Ansell Limited (ASX:ANN)

Does the May share price for Ansell Limited ( ASX:ANN ) reflect what it's really worth? Today, we will estimate the...

Shareholder Returns

ANNAU Medical EquipmentAU Market
7D-0.3%0.3%0.8%
1Y-21.9%-7.4%24.4%

Return vs Industry: ANN underperformed the Australian Medical Equipment industry which returned -7.4% over the past year.

Return vs Market: ANN underperformed the Australian Market which returned 24.4% over the past year.

Price Volatility

Is ANN's price volatile compared to industry and market?
ANN volatility
ANN Beta0.41
Industry Beta0.57
Market Beta1

Stable Share Price: ANN is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: ANN's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
189314,159Neil Salmonhttps://www.ansell.com

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, laboratories, and life sciences and pharmaceutical companies.

Ansell Fundamentals Summary

How do Ansell's earnings and revenue compare to its market cap?
ANN fundamental statistics
Market CapUS$2.88b
Earnings (TTM)US$246.70m
Revenue (TTM)US$2.03b

11.8x

P/E Ratio

1.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ANN income statement (TTM)
RevenueUS$2.03b
Cost of RevenueUS$1.22b
Gross ProfitUS$810.00m
ExpensesUS$563.30m
EarningsUS$246.70m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

Feb 15, 2022

Earnings per share (EPS)2.01
Gross Margin39.96%
Net Profit Margin12.17%
Debt/Equity Ratio28.9%

How did ANN perform over the long term?

See historical performance and comparison

Dividends

3.7%

Current Dividend Yield

40%

Payout Ratio

Valuation

Is Ansell undervalued compared to its fair value and its price relative to the market?

44.9%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: ANN (A$31.5) is trading below our estimate of fair value (A$57.16)

Significantly Below Fair Value: ANN is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: ANN is good value based on its PE Ratio (11.8x) compared to the Australian Medical Equipment industry average (13.6x).

PE vs Market: ANN is good value based on its PE Ratio (11.8x) compared to the Australian market (20x).


Price to Earnings Growth Ratio

PEG Ratio: ANN is poor value based on its PEG Ratio (56.2x)


Price to Book Ratio

PB vs Industry: ANN is good value based on its PB Ratio (1.9x) compared to the AU Medical Equipment industry average (4.5x).


Future Growth

How is Ansell forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?

0.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ANN's forecast earnings growth (0.2% per year) is below the savings rate (1.9%).

Earnings vs Market: ANN's earnings (0.2% per year) are forecast to grow slower than the Australian market (12.4% per year).

High Growth Earnings: ANN's earnings are forecast to grow, but not significantly.

Revenue vs Market: ANN's revenue (1.4% per year) is forecast to grow slower than the Australian market (5.3% per year).

High Growth Revenue: ANN's revenue (1.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ANN's Return on Equity is forecast to be low in 3 years time (12.4%).


Past Performance

How has Ansell performed over the past 5 years?

11.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ANN has high quality earnings.

Growing Profit Margin: ANN's current net profit margins (12.2%) are higher than last year (9.7%).


Past Earnings Growth Analysis

Earnings Trend: ANN's earnings have grown by 11.7% per year over the past 5 years.

Accelerating Growth: ANN's earnings growth over the past year (57.5%) exceeds its 5-year average (11.7% per year).

Earnings vs Industry: ANN earnings growth over the past year (57.5%) underperformed the Medical Equipment industry 74.9%.


Return on Equity

High ROE: ANN's Return on Equity (15.9%) is considered low.


Financial Health

How is Ansell's financial position?


Financial Position Analysis

Short Term Liabilities: ANN's short term assets ($1.2B) exceed its short term liabilities ($549.9M).

Long Term Liabilities: ANN's short term assets ($1.2B) exceed its long term liabilities ($623.2M).


Debt to Equity History and Analysis

Debt Level: ANN's debt to equity ratio (28.9%) is considered satisfactory.

Reducing Debt: ANN's debt to equity ratio has reduced from 60.8% to 28.9% over the past 5 years.

Debt Coverage: ANN's debt is well covered by operating cash flow (38.3%).

Interest Coverage: ANN's interest payments on its debt are well covered by EBIT (19.6x coverage).


Balance Sheet


Dividend

What is Ansell current dividend yield, its reliability and sustainability?

3.69%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: ANN's dividend (3.69%) is higher than the bottom 25% of dividend payers in the Australian market (2.23%).

High Dividend: ANN's dividend (3.69%) is low compared to the top 25% of dividend payers in the Australian market (5.32%).


Stability and Growth of Payments

Stable Dividend: ANN's dividends per share have been stable in the past 10 years.

Growing Dividend: ANN's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (40%), ANN's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: ANN's dividends in 3 years are forecast to be well covered by earnings (45.1% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.4yrs

Average management tenure


CEO

Neil Salmon (52 yo)

0.083

Tenure

US$3,946,760

Compensation

Mr. Neil I. Salmon, BA, ACMA, serves as the Managing Director & Chief Executive Office at Ansell Limited since September 1, 2021 and serves as its Director since 2021. He served as the President of Industr...


CEO Compensation Analysis

Compensation vs Market: Neil's total compensation ($USD3.95M) is above average for companies of similar size in the Australian market ($USD1.79M).

Compensation vs Earnings: Neil's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: ANN's management team is considered experienced (2.4 years average tenure).


Board Members

Experienced Board: ANN's board of directors are considered experienced (4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: ANN insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Ansell Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Ansell Limited
  • Ticker: ANN
  • Exchange: ASX
  • Founded: 1893
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: AU$3.843b
  • Shares outstanding: 122.78m
  • Website: https://www.ansell.com

Number of Employees


Location

  • Ansell Limited
  • 678 Victoria Street
  • Level 3
  • Richmond
  • Victoria
  • 3121
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/26 07:01
End of Day Share Price2021/10/26 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.